Lindsay joined the European Vaccine Initiative in December 2025 as a Clinical Project Manager. She coordinates and supports the preclinical and early clinical development of promising vaccine candidates aimed at addressing major public health challenges, particularly those disproportionately affecting low- and middle-income countries.
She holds a PhD in Oncology from Maastricht University (the Netherlands), a Master’s degree in Pathological Sciences from Sheffield Hallam University (United Kingdom), and a Bachelor’s degree in Molecular Cell Biology from the University of York (United Kingdom). With over five years of experience in the clinical trial setting, Lindsay brings strong expertise in coordinating and managing multi-centre clinical trials, including regulatory submissions, safety oversight, trial logistics, and reporting.
Lindsay is strongly committed to advancing global health through impactful research and clinical development.